GlassScriptPhysician profile
Robinson H Stubley
NPI 1962457879
$744.44
in general payments reported to CMS, 2019-2025
13 companies · $328 in 2025
The $328 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $26.00 · 2022: $75.07 · 2023: $201 · 2024: $115 · 2025: $328.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $643.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $643.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $237.20 | 2023-2025 | Veozah, Myrbetriq |
| Hologic Sales and Service, LLC | $145.06 | 2019-2025 | Fluent Fluid Management System, Aptima, Novasure |
| Abbvie INC. | $61.09 | 2022-2023 | Orilissa, Lo Loestrin Fe |
| Sage Therapeutics, LLC | $54.72 | 2024-2025 | Zurzuvae |
| Bayer Healthcare Pharmaceuticals INC. | $45.33 | 2025 | |
| Sumitomo Pharma America, INC. | $41.86 | 2023 | Gemtesa, Myfembree |
| Organon LLC | $35.74 | 2024-2025 | Jada System |
| Pacira Pharmaceuticals Incorporated | $27.43 | 2025 | Exparel |
| Millicent US INC | $23.74 | 2025 | Femring, Intrarosa |
| Optumhealth Care Solutions, LLC | $19.98 | 2025 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Amgen INC. | $17.51 | 2025 | Evenity |
| Pfizer INC. | $17.42 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $17.36 | 2025 | Xifaxan |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robinson Stubley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.